scholarly journals New therapeutic option for irritable bowel syndrome: Serum-derived bovine immunoglobulin

2015 ◽  
Vol 21 (11) ◽  
pp. 3361-3366 ◽  
Author(s):  
Larry Good ◽  
Roxanne Rosario ◽  
Raymond Panas
2013 ◽  
Vol 144 (5) ◽  
pp. S-233
Author(s):  
Dale Wilson ◽  
Eric Weaver ◽  
Gerald L. Klein ◽  
Audrey L. Shaw ◽  
Malkanthi Evans ◽  
...  

Author(s):  
Saeed Yazdani Ashtiani ◽  
Mersad Amery

Background: Irritable bowel syndrome (IBS) is a common, chronic and sometimes disabling functional disorder of the gastrointestinal system and its treatment remains as health problem. Thus the aim of this study was to evaluate the Effect of multispecies probiotic supplementation, as a novel and Controversial therapeutic method on Irritable bowel syndrome. Materials and Methods: In this randomized double blind Placebo-controlled clinical trial, 60 patients with IBS were enrolled. The patients were divided randomly into two groups. Patients in intervention group received two 500 mg probiotic capsules (Familact®) and in control group, received two 500 mg placebo capsules daily for 30 consecutive days. The symptoms and quality of life were measured and compared at the beginning and just after the end of study for each case. Results: Results showed the mean score of Abdominal pain after 1 month of treatment in the probiotic group was significantly lower than the control group (1.76 ± 2.04 vs. 2.88 ± 2.25, P=0.049, respectively). While, other symptoms and quality of life did not change significantly (P>0.05). Furthermore, defecation habit and global symptoms improvement was similar after intervention in both groups and we did not observe significant differences in these items (P>0.05). Conclusion: The results of this study showed the beneficial effects of multispecies probiotic supplementation in controlling IBS patients’ abdominal pain. thus it can be prescribed as a therapeutic option in addition to standard therapy and significantly lead to better control of this symptom in the short term.


2018 ◽  
Vol 43 (5) ◽  
pp. 752-756 ◽  
Author(s):  
Qin Xiang Ng ◽  
Alex Yu Sen Soh ◽  
Donovan Yutong Lim ◽  
Wee‐Song Yeo

Author(s):  
Malayala Tejaswini ◽  
Tarun Ponugoti ◽  
Anthireddy Sahithreddy

Irritable Bowel Syndrome (IBS) is characterized by chronic relapsing abdominal pain, bloating and changes in bowel habits. Despite very real symptoms, the gross and microscopy evaluation is normal in most IBS patients Due to difficulty in diagnosis, incidence is not clearly known. Prevalence in developed countries is between 5% and 10 percent. Throughout the world about 10-20 percent of adults and adolescents have symptoms consistent with IBS.IBS is a disorder that effect all ages although most patients have their first symptom before age 45.Older individuals have a lover reporting frequency. Women are diagnosed with IBS 2-3 times as often as men and makeup 80 percent of population with severe IBS. IBS is a bio-psychosocial disorder in which 3 major mechanicals interact: psychosocial factors, altered motility and heightened sensory function of intestine. Due to multifactorial etiology there is no single therapeutic option available with satisfactory efficiency. Therefore, patients with high frequency of symptoms express high levels of frustration with their frequent hospital visits, decreased work & social life and food sensitivity. If treatment is carried out to improve symptoms, some people can control their symptoms by managing diet, lifestyle and stress. Others need medication and counselling. In our case the patient wasn’t satisfied with the pharmacotherapy alone. He used diet modification and lifestyle modification as a main treatment strategy. Satisfactory results were observed with such changes. Keywords: IBS, psychosocial, bio-psychosocial, lifestyle modification, diet modification, low FODMAP diet, high fiber diet, yoga, stress


2018 ◽  
Vol Volume 9 ◽  
pp. 129-133 ◽  
Author(s):  
Rami Arrouk ◽  
Rachel E Herdes ◽  
Aryn C Karpinski ◽  
Paul E Hyman

Sign in / Sign up

Export Citation Format

Share Document